Biopharma vet Deborah Dunsire has joined Waltham, Massachusetts-based XTuit Pharmaceuticals, a startup targeting the microenvironments that protect and drive certain cancers and fibrotic diseases.
The therapeutic development's based on microenvironment modulators that target the disease-causing mechanisms of immuno-oncology and fibrotic diseases.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.